Detalles de la búsqueda
1.
Phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320).
Invest New Drugs
; 39(2): 530-536, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159674
2.
Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial.
JAMA Oncol
; 6(7): e201250, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32407455
3.
A phase I/II trial of weekly nab-paclitaxel for pretreated non-small-cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement.
Asia Pac J Clin Oncol
; 15(4): 250-256, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30938103
4.
Successful Long-term Management of Two Cases of Moderate Hemoptysis Due to Chronic Cavitary Pulmonary Aspergillosis with Bronchial Occlusion Using Silicone Spigots.
Intern Med
; 57(16): 2389-2393, 2018 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29607955
5.
Statistical analysis of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography ground-glass nodule findings.
Mol Clin Oncol
; 9(3): 279-282, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30155250
6.
A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404.
Lung Cancer
; 115: 103-108, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29290249
7.
Cerebral venous sinus thrombosis concomitant with leptomeningeal carcinomatosis, in a patient with epidermal growth factor receptor-mutated lung cancer.
Oncol Lett
; 8(6): 2489-2492, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25364413
Resultados
1 -
7
de 7
1
Próxima >
>>